ebcc 7: ways to predict efficacy of anthracyclines
Published 14 years ago • 606 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
3:34
ebcc 7: management of symptoms in women with breast cancer
-
30:40
prediction of response to anthracycline-based chemotherapy in early breast cancer
-
7:23
san antonio breast cancer symposium 2008: new biomarker predicts anthracycline response.
-
12:13
cd4 t cells in inflitrated breast cancer signal immune response and predict survival
-
22:34
pharmacogenomic prediction of antracycline-induced cardiotoxicity
-
1:18
dr. levis discusses the ideal use of quizartinib in flt3-itd aml
-
5:57
should anthracyclines be given in advanced gastroesophageal cancer?
-
8:11
ieo interviews: managing cardiotoxicity while treating cancer
-
0:15
oncology for students: are the acute side effects of anthracyclines related to the dose?
-
0:57
nivolumab/ docetaxel shows promise for nsclc in checkmate 057 trial
-
6:08
oncohost develops predictive biomarker for iraes in nsclc
-
1:48
upcoming io combinations for advanced hcc
-
4:17
adaptive tonic trial of nivolumab combinations for breast cancer
-
14:05
checkmate-77t: perioperative nivolumab benefit for nsclc
-
2:24
emerging i-o combination trials in unresectable hcc
-
6:43
exomechip identifies 10 novel qt loci
-
2:45
[7] combination of erlotinib and egcg induces apoptosis of head and neck cancers through-
-
1:06
anthracycline - medical meaning
-
1:23
future directions for liquid biopsy research